Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Key details about Lp(a) | TAVR momentum for Edwards | New scaffold shows promise | Progress for heart catheter | $50M donated

News You Need to Know Today
Key details about Lp(a) | TAVR momentum for Edwards | New scaffold shows promise | Progress for heart catheter | $50M donated
Thursday, February 12, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks

Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.

READ MORE >
Nathaniel Lebowitz, MD, in charge of preventive cardiology at Hackensack University Medical Center, and assistant professor of internal medicine at Hackensack Meridian School of Medicine, gives an overview of where things are at with lipoprotein (a) awareness, testing and drug development. He and is working on the American Heart Associations (AHA) Lp(a) Discovery Project to expand awareness to both physicians and patients. #AHA #LPA
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks

Share on Twitter Share on Facebook Share on Linkedin
Nathaniel Lebowitz, MD, in charge of preventive cardiology at Hackensack University Medical Center, and assistant professor of internal medicine at Hackensack Meridian School of Medicine, gives an overview of where things are at with lipoprotein (a) awareness, testing and drug development. He and is working on the American Heart Associations (AHA) Lp(a) Discovery Project to expand awareness to both physicians and patients. #AHA #LPA
Cardiologist Nathaniel Lebowitz, MD, reviews the latest updates in lipoprotein(a) awareness, testing and drug development.
READ MORE >

Edwards celebrates double-digit TAVR sales growth in Q4

It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry. 

READ MORE >
REVENUE MONEY INCREASE DOLLAR GRAPH FINANCE
Share on Twitter Share on Facebook Share on Linkedin

Edwards celebrates double-digit TAVR sales growth in Q4

Share on Twitter Share on Facebook Share on Linkedin
REVENUE MONEY INCREASE DOLLAR GRAPH FINANCE
It was another strong quarter for Edwards Lifesciences as the company's TAVR platform continues to gain momentum. The FDA's approval of multiple Edwards valves for the treatment of asymptomatic severe AS represents a potential game-changer for the entire industry. 
READ MORE >

Ultrathin iron bioresorbable scaffold shows promise in first randomized trial

An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC. 

READ MORE >
iron bioresorbable scaffold Biotyx Medical
Share on Twitter Share on Facebook Share on Linkedin

Ultrathin iron bioresorbable scaffold shows promise in first randomized trial

Share on Twitter Share on Facebook Share on Linkedin
iron bioresorbable scaffold Biotyx Medical
An investigational device could help interventional cardiologists avoid the limitations of drug-eluting stents, according to a new analysis published in JACC. 
READ MORE >

New heart catheter for cell therapy delivery 1 step closer to FDA approval

The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue. 

READ MORE >
progress step forward business announce
Share on Twitter Share on Facebook Share on Linkedin

New heart catheter for cell therapy delivery 1 step closer to FDA approval

Share on Twitter Share on Facebook Share on Linkedin
progress step forward business announce
The BioCardia delivery catheter was designed to be used by interventional cardiologists, electrophysiologists or cardiac surgeons. It includes a tiny needle that directly engages with the patient’s cardiac tissue. 
READ MORE >

Billionaire donates $50M to advance cardiovascular care at Northwestern

Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name.

READ MORE >
Jane E Wilcox, MD, and Neil G. Bluhm. Image courtesy of Northwestern.
Share on Twitter Share on Facebook Share on Linkedin

Billionaire donates $50M to advance cardiovascular care at Northwestern

Share on Twitter Share on Facebook Share on Linkedin
Jane E Wilcox, MD, and Neil G. Bluhm. Image courtesy of Northwestern.
Neil G. Bluhm, a billionaire philanthropist with deep ties to Chicago, has donated an additional $50 million to a high-volume facility that already bears his name.
READ MORE >

Featured Articles

Reprocessed EP catheters recalled due to contamination risk

The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. 

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

Reprocessed EP catheters recalled due to contamination risk

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The FDA has announced seven Class I recalls related to this issue. Customers are urged to destroy the devices immediately instead of returning them to the manufacturer. 
READ MORE >

New initiative to fund pulmonary embolism research

Grants from $50,000 to $750,000 will be awarded to pay for physician-led studies focused on PE care.

READ MORE >
Example of spectral, or dual-energy CT, confirming a pulmonary embolism (PE). Image courtesy of Philips Healthcare
Share on Twitter Share on Facebook Share on Linkedin

New initiative to fund pulmonary embolism research

Share on Twitter Share on Facebook Share on Linkedin
Example of spectral, or dual-energy CT, confirming a pulmonary embolism (PE). Image courtesy of Philips Healthcare
Grants from $50,000 to $750,000 will be awarded to pay for physician-led studies focused on PE care.
READ MORE >

Blood glucose monitor instructions updated due to error code linked to 114 injuries

No devices need to be returned or replaced, but the company did want to update their instructions for use. 

READ MORE >
Trividia Health True Metrix
Share on Twitter Share on Facebook Share on Linkedin

Blood glucose monitor instructions updated due to error code linked to 114 injuries

Share on Twitter Share on Facebook Share on Linkedin
Trividia Health True Metrix
No devices need to be returned or replaced, but the company did want to update their instructions for use. 
READ MORE >

ECG market keeps evolving thanks to AI, home monitoring and Epic integration

For years, the ECG market was relatively static. According to a new report, however, things are rapidly changing. 

READ MORE >
The HeartBeam AIMIGo device is approximately the size of a credit card and uses the company’s patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthesized 12-lead ECG.
Share on Twitter Share on Facebook Share on Linkedin

ECG market keeps evolving thanks to AI, home monitoring and Epic integration

Share on Twitter Share on Facebook Share on Linkedin
The HeartBeam AIMIGo device is approximately the size of a credit card and uses the company’s patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthesized 12-lead ECG.
For years, the ECG market was relatively static. According to a new report, however, things are rapidly changing. 
READ MORE >

Stroke risk after TAVR still higher for woman as ‘sex paradox’ lives on

By tracking sex-related differences after TAVR, researchers hope to refine patient selection strategies and optimize care for both men and women.

READ MORE >
a patient talks with her doctor, both are women of color
Share on Twitter Share on Facebook Share on Linkedin

Stroke risk after TAVR still higher for woman as ‘sex paradox’ lives on

Share on Twitter Share on Facebook Share on Linkedin
a patient talks with her doctor, both are women of color
By tracking sex-related differences after TAVR, researchers hope to refine patient selection strategies and optimize care for both men and women.
READ MORE >

In Case You Missed It

STEMI cases bring high doses of radiation to the cath lab

“We're so focused on quickly taking care of the patient ... we may be forgetting about radiation safety,” one researcher explained. 

READ MORE >
Ryan Madder, MD, Program Director, Interventional Cardiology Fellowship, William Beaumont University Hospital, Corewell Health East, and Michael Abiragi, MD, cardiology fellow, Frederik Meijer Heart and Vascular Institute, Corewell Health West in Grand Rapids, explain a study showing a small number of high dose cases contribute the majority of staff dose, especially STEMI.
Share on Twitter Share on Facebook Share on Linkedin

STEMI cases bring high doses of radiation to the cath lab

Share on Twitter Share on Facebook Share on Linkedin
Ryan Madder, MD, Program Director, Interventional Cardiology Fellowship, William Beaumont University Hospital, Corewell Health East, and Michael Abiragi, MD, cardiology fellow, Frederik Meijer Heart and Vascular Institute, Corewell Health West in Grand Rapids, explain a study showing a small number of high dose cases contribute the majority of staff dose, especially STEMI.
“We're so focused on quickly taking care of the patient ... we may be forgetting about radiation safety,” one researcher explained. 
READ MORE >

Johnson & Johnson CEO celebrates company’s cardiovascular business during Q4 earnings call

Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.

READ MORE >
startup business healthcare medtech heart
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson CEO celebrates company’s cardiovascular business during Q4 earnings call

Share on Twitter Share on Facebook Share on Linkedin
startup business healthcare medtech heart
Johnson & Johnson reported $24.6 billion in sales for the fourth quarter of 2025, up 9.1% from the previous year. On an earnings call with investors, the company's CEO sang the praises of the company's cardiovascular health division.
READ MORE >

FDA-approved PFA system linked to positive 1-year data, ‘impeccable’ durability

The Globe Pulsed Field System, which secured FDA approval in September 2025, features high-density mapping capabilities and a 122-electrode spherical array.

READ MORE >
Kardium, a Canadian medical device company focused on electrophysiology technologies, has raised $104 million in new financing. mages of the Globe Pulsed Field System courtesy of Kardium
Share on Twitter Share on Facebook Share on Linkedin

FDA-approved PFA system linked to positive 1-year data, ‘impeccable’ durability

Share on Twitter Share on Facebook Share on Linkedin
Kardium, a Canadian medical device company focused on electrophysiology technologies, has raised $104 million in new financing. mages of the Globe Pulsed Field System courtesy of Kardium
The Globe Pulsed Field System, which secured FDA approval in September 2025, features high-density mapping capabilities and a 122-electrode spherical array.
READ MORE >

In Other News

California-based patient care coordination company hits $1B valuation with $130M in new funding

Solace Health, a company that connects patients with an "advocate" to help them navigate the U.S. healthcare system after a diagnosis, announced on Tuesday that it's earned $130 million in Series C funding, bringing its valuation to the coveted “unicorn status."

READ MORE >
Investment
Share on Twitter Share on Facebook Share on Linkedin

California-based patient care coordination company hits $1B valuation with $130M in new funding

Share on Twitter Share on Facebook Share on Linkedin
Investment
Solace Health, a company that connects patients with an "advocate" to help them navigate the U.S. healthcare system after a diagnosis, announced on Tuesday that it's earned $130 million in Series C funding, bringing its valuation to the coveted “unicorn status."
READ MORE >

Large-language AI models aren’t immune to medical misinformation, but they can learn to discern

Medical AI is likely to pass along potentially dangerous misinformation when the distortion comes to the model from a normally trustworthy source using a convincingly authoritative voice. 

READ MORE >
LLM
Share on Twitter Share on Facebook Share on Linkedin

Large-language AI models aren’t immune to medical misinformation, but they can learn to discern

Share on Twitter Share on Facebook Share on Linkedin
LLM
Medical AI is likely to pass along potentially dangerous misinformation when the distortion comes to the model from a normally trustworthy source using a convincingly authoritative voice. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup